IFN-γ production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin- HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population

被引:30
作者
Best, Ivan [1 ]
Lopez, Giovanni [1 ]
Verdonck, Kristien [1 ,2 ,3 ]
Gonzalez, Elsa [1 ,4 ]
Tipismana, Martin [1 ,4 ]
Gotuzzo, Eduardo [1 ,4 ]
Vanham, Guido [2 ,3 ]
Clark, Daniel [1 ,5 ]
机构
[1] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru
[2] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium
[3] Inst Trop Med, Dept Microbiol, Virol Unit, B-2000 Antwerp, Belgium
[4] Univ Peruana Cayetano Heredia, Dept Med, Fac Med, Lima 31, Peru
[5] Univ Peruana Cayetano Heredia, LID, Fac Ciencias & Filosofia, Lima 31, Peru
关键词
CD8(+) T-cell response; human T-lymphotropic virus 1; paraparesis; tropical spastic; provirus load; T lymphocytes; regulatory; TROPICAL SPASTIC PARAPARESIS; CYTOTOXIC T-LYMPHOCYTES; I PROVIRAL LOAD; LEUKEMIA-VIRUS; DENDRITIC CELLS; INFECTION; HTLV-1; EXPRESSION; CARRIERS; RECOGNITION;
D O I
10.1111/j.1365-2567.2009.03082.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>Human T-lymphotropic virus 1 (HTLV-1) can cause HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The objective of this study was to gain insight into the pathogenesis of HAM/TSP by focusing on the CD8(+) T-cell response. Twenty-three HTLV-1-seronegative controls (SC), 29 asymptomatic HTLV-1 carriers (AC) and 48 patients with HAM/TSP were enrolled in the study. We evaluated the production of interferon-gamma (IFN-gamma) in peripheral blood mononuclear cells stimulated with Tax overlapping peptides, the expression of genes related to the CD8(+) cytotoxic T-cell response, the frequency of CD4(+) Foxp3(+) cells and of dendritic cells, and the HTLV-1 provirus load (PVL). The frequency of cells producing IFN-gamma in response to Tax 161-233, but not to Tax 11-19, discriminated patients with HAM/TSP from AC. The increased pro-inflammatory response observed in patients with HAM/TSP was shared by AC with a high PVL, who also exhibited lower levels of granzyme H mRNA in unstimulated CD8(+) T cells than AC with a low PVL. Patients with HAM/TSP showed higher frequencies of CD4(+) Foxp3(+) cells and lower frequencies of plasmacytoid dendritic cells (pDC) than AC. Our findings are consistent with a model in which HTLV-1, along with the host genetic background, drives quantitative and qualitative changes in pDC and CD4(+) Foxp3(+) cells that lead to a predominance of inflammatory responses over lytic responses in the CD8(+) T-cell response of individuals predisposed to develop HAM/TSP.
引用
收藏
页码:e777 / e786
页数:10
相关论文
共 40 条
  • [1] SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers:: Influence of clinical status, sex, and familial relatedness
    Adaui, Vanessa
    Verdonck, Kristien
    Best, Ivan
    Gonzalez, Elsa
    Tipismana, Martin
    Arevalo, Jorge
    Vanham, Guido
    Campos, Miguel
    Zimic, Mirko
    Gotuzzo, Eduardo
    [J]. JOURNAL OF NEUROVIROLOGY, 2006, 12 (06) : 456 - 465
  • [2] Quantification of the virus-host interaction in human T lymphotropic virus I infection
    Asquith, B
    Mosley, AJ
    Heaps, A
    Tanaka, Y
    Taylor, GP
    McLean, AR
    Bangham, CRM
    [J]. RETROVIROLOGY, 2005, 2 (1)
  • [3] How does HTLV-I persist despite a strong cell-mediated immune response?
    Asquith, Becca
    Bangharn, Charles R. M.
    [J]. TRENDS IN IMMUNOLOGY, 2008, 29 (01) : 4 - 11
  • [4] Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru
    Best, I.
    Adaui, V.
    Verdonck, K.
    Gonzalez, E.
    Tipismana, M.
    Clark, D.
    Gotuzzo, E.
    Vanham, G.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 146 (02) : 226 - 233
  • [5] CD8 T cell responses to viral infections in sequence
    Brehm, MA
    Selin, LK
    Welsh, RM
    [J]. CELLULAR MICROBIOLOGY, 2004, 6 (05) : 411 - 421
  • [6] Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM)
    De Castro-Costa, Carlos M.
    Araujo, Abelardo Q. C.
    Barreto, Marcio M.
    Takayanagui, Osvaldo M.
    Sohler, Marzia P.
    Da Silva, Eduardo L. M.
    De Paula, Sonia M. B.
    Ishak, Ricardo
    Ribas, Joao G. R.
    Rovirosa, Luis C.
    Carton, Herwig
    Gotuzzo, Eduardo
    Hall, William W.
    Montano, Silvia
    Murphy, Edward L.
    Oger, Joel
    Remondegui, Carlos
    Taylor, Graham P.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (10) : 931 - 935
  • [7] HTLV type 1 genetic types among native descendants in Argentina
    Gastaldello, Rene
    Iniguez, Alena Mayo
    Otsuki, Koko
    Lamas, Gabriela
    Balangero, Marcos
    Barbas, Maria Gabriela
    Mangano, Andrea
    Sen, Luisa
    Maturano, Eduardo
    Remondegui, Carlos
    Paulo Vicente, Ana Carolina
    Gallego, Sandra
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (09) : 1139 - 1146
  • [8] Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells:: Frequency and immunodominance hierarchy
    Goon, PKC
    Biancardi, A
    Fast, N
    Igakura, T
    Hanon, E
    Mosley, AJ
    Asquith, B
    Gould, KG
    Marshall, S
    Taylor, GP
    Bangham, CRM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (12) : 2294 - 2298
  • [9] Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells:: Immunodominance hierarchy and preferential infection with HTLV-I
    Goon, PKC
    Igakura, T
    Hanon, E
    Mosley, AJ
    Barfield, A
    Barnard, AL
    Kaftantzi, L
    Tanaka, Y
    Taylor, GP
    Weber, JN
    Bangham, CRM
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (03) : 1735 - 1743
  • [10] Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis
    Gotuzzo, E
    Cabrera, J
    Deza, L
    Verdonck, K
    Vandamme, AM
    Cairampoma, R
    Vizcarra, D
    Cabada, M
    Narvarte, G
    De las Casas, C
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 939 - 944